South America News
Filter News
Found 1,533 articles
-
Governments across the globe have flexed their financial muscles to secure promises of as many doses of COVID-19 vaccines as possible when they become available.
-
Afya Limited to Report Third Quarter 2020 Financial Results on December 3rd
11/24/2020
Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report third quarter 2020 financial results for the period ended September 30, 2020, following the close of the market on Thursday, December 3rd, 2020.
-
Genomma Lab Internacional Becomes A Constituent Of The Dow Jones Sustainability MILA Pacific Alliance Index
11/23/2020
Genomma Lab Internacional, S.A.B. de C.V. announced its inclusion in the "Dow Jones Sustainability MILA Pacific Alliance Index" with the highest sustainability standards in Mexico and other countries in Latin America among a select group of companies recognized for excellence in Sustainability and Corporate Governance practices.
-
Triple-S Management Corporation to Present at the Stephens Annual Investment Conference 2020
11/16/2020
Triple-S Management Corporation (NYSE: GTS) today announced that President and Chief Executive Officer Roberto García-Rodríguez, and EVP and Chief Financial Officer Juan José Román-Jiménez, will present at the Stephens Annual Investment Conference 2020 on Thursday, November 19, 2020 via live webcast
-
Bioceres Crop Solutions Corp. Acquires full Ownership of HB4® Soy and Strategic Intellectual Property Rights for Wheat
11/12/2020
Bioceres Crop Solutions Corp., a fully-integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced that it has entered into definitive agreements for the acquisition of the remaining 50% ownership interest in Verdeca LLC as well as strategic Intellectual Property assets related to soybean and wheat from Arcadia Biosciences Inc.
-
VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize
11/12/2020
In a year in which healthcare and biomedical-related innovations have become the center of the discussion in an effort to fight the Covid-19 pandemic, the Chilean biotech company Cells for Cells won the 2020 Avonni Prize for the R&D of Veintis™, a personalized tissue-engineered vascular graft.
-
When it comes to a novel virus like SARS-CoV2, a certain amount of “rolling with the punches” is required, and governments and global organizations like the World Health Organization are beginning to dismiss certain treatments and devote themselves wholeheartedly to others.
-
Bioceres Crop Solutions Corp. Announces Date of Fiscal First Quarter 2021 Earnings Release, Conference Call and Webcast
11/3/2020
Bioceres Crop Solutions Corp. (“Bioceres”) (NYSE American: BIOX), a fully-integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, today announced that it plans to release its Fiscal First Quarter 2021 financial and operating results on Thursday, November 12, 2020 before the market open of the New York Stock Exchange
-
miR Scientific and Puerto Rico Government Announce Pioneering Cooperation Agreement to Evaluate Impact and Deployment of its Prostate Cancer Liquid Biopsy Test in Puerto Rico
11/2/2020
miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management, and the Puerto Rico Health Insurance Administration ("ASES") announced today the signing of a cooperation agreement aimed at evaluating the clinical and economic utility of the miR Sentinel™ PCC4 Assay (miR Sentinel™ Prostate Test) and its potential impact in Puerto Rico.
-
BioSpace provides an up-to-date overview of these deals and the projected COVID-19 vaccine doses each company plans to have within the next couple of years.
-
Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials
10/29/2020
WUHAN GENERAL GROUP, INC., a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following corporate update
-
The Global Cost of Containing COVID-19
9/25/2020
Even when a first vaccine is finally approved, much of the developing world currently stands to be left behind, as it was during the 2009 H1N1 pandemic. -
More than 150 countries have signed on to a World Health Organization program to ensure global access to a COVID-19 vaccine, however, the United States, Russia and China refrained from signing the agreement.
-
Pharma-Bio Serv Files 10-Q for the Quarter Ended July 31, 2020
9/14/2020
Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced it has filed its Quarterly Report on Form 10-Q for the quarter ended July 31, 2020.
-
Nanox Signs Agreement With SPI Medical for the Deployment of 630 Nanox.ARC Units in Mexico
9/9/2020
Subject to regulatory approval and acceptance test, the agreement guarantees minimum service fees of $119 million to Nanox over seven years aiming to service both public and private sectors
-
First U.S. Lab Implements AI-based Solution for Cancer Detection in Pathology
9/1/2020
CorePlus Servicios Clínicos y Patológicos, LLC, a high complexity CLIA-certified clinical and anatomic pathology laboratory, today announced the first deployment in the Americas of an artificial intelligence (AI) powered digital pathology solution for detecting prostate cancer at its main facilities in Carolina.
-
Genomma Lab Internacional Successfully Issues One Billion Pesos LAB-20 Unsecured Bond In The Mexican Stock Exchange
8/31/2020
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announces the successful issuance of unsecured Mexican corporate bonds (Cebures) for a total amount of Ps. 1,000,000,000.00 (one billion Mexican pesos
-
Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of Faculdade de Ensino Superior da Amazônia Reunida
8/27/2020
Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade de Ensino Superior da Amazônia Reunida, or FESAR.
-
Afya Limited Announces Second Quarter and First Half 2020 Financial ResultsSurpassed 1H20 Guidance; Synergies and Maturation Driving Margin Expansion
8/27/2020
Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group in Brazil, today reported financial and operating results for the three and six-month periods ended June 30, 2020 (second quarter 2020, 2Q20 and first half 2020, respectively
-
Emergex and Bio-Manguinhos/Fiocruz Elucidate T Cell Epitopes Produced by Commercial Yellow Fever Vaccine
8/19/2020
First identification of epitopes which shape CD8 T cell response to commercial live attenuated vaccine has implications across RNA virus vaccine development